Der-Jen Yen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Der-Jen Yen has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Chien Chen
Department of Neurology Neurological Institute Taipei Veterans General Hospital and National Yang‐Ming University Taipei Taiwan
8 shared publications- Hsiang-Yu Yu
Department of Neurology, Neurological Institute Taipei Veterans General Hospital Taipei Taiwan
7 shared publications Chun‐Hing Yiu
Radiology, The Neurological Institute, Taipei Veterans General Hospital and School of Medicine, National Yang‐Ming University, Taipei, Taiwan
4 shared publicationsYuh‐Cherng Guo
Radiology, The Neurological Institute, Taipei Veterans General Hospital and School of Medicine, National Yang‐Ming University, Taipei, Taiwan
4 shared publicationsChun-Hing Yiu
3 shared publicationsShang‐Yeong Kwan
Department of Neurology Neurological Institute Taipei Veterans General Hospital and National Yang‐Ming University Taipei Taiwan
3 shared publications
Latest Publications
- Open Access
The Social and Occupational Functioning Scale for Epilepsy (SOFSE): A brief measure of functional status in a Taiwanese sample with epilepsy
Purpose To develop and validate a scale of social functioning for people with epilepsy (PWE)—the Social and Occupational Functioning Scale for Epilepsy (SOFSE). Methods According to the literature review and opinions from a panel of experts, PWE, and caregivers, a total of 31 questions were compiled. Questionnaires were analyzed from 172 adults with epilepsy. Key Findings The final scale had 30 items in six dimensions. The results showed that internal consistency coefficients and test–retest reliabilities for each dimension ranged from 0.70 to 0.84 and 0.72 to 0.89, respectively. Retest reliability for the total SOFSE score was 0.92. Seven factors were extracted through principal factor analysis. Moreover, criterion-related validity was demonstrated by the significant correlations between the SOFSE and the following measures: the Mini Mental Status Examination (r = 0.60, p < 0.001), the Quality of Life in Epilepsy-31 (r = 0.53, p < 0.001), and the Global Severity Index of the Symptom Checklist-90-Revised (r = −0.66, p < 0.001). Finally, the differences in functional competence among patients also supported the discriminant validity of the inventory. Significance The SOFSE is a brief, psychometrically sound, and easy-to-administer measure of social functioning for use in busy clinical settings.
Open AccessThe Social and Occupational Functioning Scale for Epilepsy (SOFSE): A brief measure of functional status in a Taiwanese sample with epilepsy
Purpose To develop and validate a scale of social functioning for people with epilepsy (PWE)—the Social and Occupational Functioning Scale for Epilepsy (SOFSE). Methods According to the literature review and opinions from a panel of experts, PWE, and caregivers, a total of 31 questions were compiled. Questionnaires were analyzed from 172 adults with epilepsy. Key Findings The final scale had 30 items in six dimensions. The results showed that internal consistency coefficients and test–retest reliabilities for each dimension ranged from 0.70 to 0.84 and 0.72 to 0.89, respectively. Retest reliability for the total SOFSE score was 0.92. Seven factors were extracted through principal factor analysis. Moreover, criterion-related validity was demonstrated by the significant correlations between the SOFSE and the following measures: the Mini Mental Status Examination (r = 0.60, p < 0.001), the Quality of Life in Epilepsy-31 (r = 0.53, p < 0.001), and the Global Severity Index of the Symptom Checklist-90-Revised (r = −0.66, p < 0.001). Finally, the differences in functional competence among patients also supported the discriminant validity of the inventory. Significance The SOFSE is a brief, psychometrically sound, and easy-to-administer measure of social functioning for use in busy clinical settings.
- 30 November 2010
- Published by Elsevier in Epilepsy & Behavior
- Vol. 19 (3) , 436-440
Postoperative interictal epileptiform discharge within 1month is associated with seizure recurrence after anterior temporal lobectomy
- 30 November 2010
- Published by Elsevier in Epilepsy & Behavior
- Vol. 19 (3) , 436-440
Postoperative interictal epileptiform discharge within 1month is associated with seizure recurrence after anterior temporal lobectomy
- 1 September 2009
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 18 (7) , 511-514
Gamma knife radiosurgery for the treatment of recurrent seizures after incomplete anterior temporal lobectomy
- 1 September 2009
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 18 (7) , 511-514
Gamma knife radiosurgery for the treatment of recurrent seizures after incomplete anterior temporal lobectomy
- 1 July 2008
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 107 (7) , 567-571
Unilateral Thalamic Hypometabolism in Patients With Temporal Lobe Epilepsy
- 1 July 2008
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 107 (7) , 567-571
Unilateral Thalamic Hypometabolism in Patients With Temporal Lobe Epilepsy
- 1 March 2006
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 15 (2) , 117-124
Selective posterior cerebral artery amobarbital test in patients with temporal lobe epilepsy for surgical treatment
- 1 March 2006
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 15 (2) , 117-124
Selective posterior cerebral artery amobarbital test in patients with temporal lobe epilepsy for surgical treatment
- 1 October 2003
- Vol. 66 (10) , 565-71
Surgery of intractable temporal lobe epilepsy presented with structural lesions.
Structural lesions are found in about 30% of surgical specimens resected for intractable temporal lobe epilepsy (TLE). Detailed presurgical evaluations can identify the epileptogenic foci, the structural lesions and their correlation. Different surgical approaches have variable seizure control outcomes. The preoperative investigations for the intractable TLE consisted of serial electroencephalogram (EEG) recordings, long-term EEG/video monitoring with sphenoidal electrodes, magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), positron emission tomography with fluorodeoxyglucose (FDG-PET) and neuropsychological assessment. Among the 217 patients who underwent anterior temporal lobectomy (ATL) for TLE at Taipei Veterans General Hospital between 1987 and 1998, 47 (21.7%) had structural lesions in the resected specimen. The patients were divided into neoplastic (n = 35) and vascular (n = 12) groups, based on the pathological findings. In the neoplastic group, the interictal scalp-sphenoidal EEG recordings were abnormal in all 35 cases and lateralizing in 30 (85.7%). MRI revealed tumor growth within the temporal lobe in 26 patients (74.3%). FDG-PET was performed on 17 patients. Fifteen (88.2%) of them revealed unilateral mesial temporal lobe hypometabolism. In the vascular group, the interictal EEG tracings revealed unilateral mesial temporal lobe spikes in 11 patients (91.6%). MRI revealed abnormal enhanced lesions within the temporal lobes in all 12 patients. FDG-PET was available for 7 patients, 6 (86%) of whom had unilateral mesial temporal lobe hypometabolism. At the last follow-up (range 2-10 years, with a mean period of 4.2 years), 25 patients (73%) in the neoplastic group became and remained seizure-free postoperatively, 3 (9%) had fewer than 3 attacks per year. Among the vascular group, all 12 patients became and remained seizure-free after surgery. For intractable TLE with structural lesions, detailed presurgical evaluations are mandatory to identify the concordance of the lesions and the epileptogenic foci. Standard ATL with removal of the lesion may offer good seizure control postoperatively.
- 1 October 2003
- Vol. 66 (10) , 565-71
Surgery of intractable temporal lobe epilepsy presented with structural lesions.
Structural lesions are found in about 30% of surgical specimens resected for intractable temporal lobe epilepsy (TLE). Detailed presurgical evaluations can identify the epileptogenic foci, the structural lesions and their correlation. Different surgical approaches have variable seizure control outcomes. The preoperative investigations for the intractable TLE consisted of serial electroencephalogram (EEG) recordings, long-term EEG/video monitoring with sphenoidal electrodes, magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), positron emission tomography with fluorodeoxyglucose (FDG-PET) and neuropsychological assessment. Among the 217 patients who underwent anterior temporal lobectomy (ATL) for TLE at Taipei Veterans General Hospital between 1987 and 1998, 47 (21.7%) had structural lesions in the resected specimen. The patients were divided into neoplastic (n = 35) and vascular (n = 12) groups, based on the pathological findings. In the neoplastic group, the interictal scalp-sphenoidal EEG recordings were abnormal in all 35 cases and lateralizing in 30 (85.7%). MRI revealed tumor growth within the temporal lobe in 26 patients (74.3%). FDG-PET was performed on 17 patients. Fifteen (88.2%) of them revealed unilateral mesial temporal lobe hypometabolism. In the vascular group, the interictal EEG tracings revealed unilateral mesial temporal lobe spikes in 11 patients (91.6%). MRI revealed abnormal enhanced lesions within the temporal lobes in all 12 patients. FDG-PET was available for 7 patients, 6 (86%) of whom had unilateral mesial temporal lobe hypometabolism. At the last follow-up (range 2-10 years, with a mean period of 4.2 years), 25 patients (73%) in the neoplastic group became and remained seizure-free postoperatively, 3 (9%) had fewer than 3 attacks per year. Among the vascular group, all 12 patients became and remained seizure-free after surgery. For intractable TLE with structural lesions, detailed presurgical evaluations are mandatory to identify the concordance of the lesions and the epileptogenic foci. Standard ATL with removal of the lesion may offer good seizure control postoperatively.
- Open Access
Olfactory Auras in Patients with Temporal Lobe Epilepsy
Summary: Purpose: To investigate olfactory auras in patients with temporal lobe epilepsy (TLE).Methods: We reviewed medical records of 217 Chinese patients who underwent temporal lobectomy for medically intractable TLE between 1987 and 1998 in Taiwan. Patients with olfactory auras asked for detailed characteristics of their auras.Results: In all, 12 (5.5%) patients had olfactory auras, seven men and five women. All patients except one described and characterized the unpleasant olfactory auras. Olfactory auras were usually combined with other auras, most frequently sensations of epigastric rising, nausea, and fear. Association with gustatory hallucination was uncommon, in only one patient. On neuroimaging study, 11 patients had structural lesions involving the mesial temporal structures, two exclusively involving the amygdala. Histologic diagnosis included gliosis of the mesial temporal regions in seven (58.3%) patients, neoplasm in four (33.3%) patients, and arteriovenous malformation in one patient. Postoperatively, eight patients were seizure free. Three patients had rare seizures; however, none reported residual olfactory auras.Conclusions: Olfactory auras are infrequent in TLE. In this study, mesial temporal sclerosis is the most common etiology rather than tumors. Mesial temporal structures, especially the amygdala, may play important roles in the genesis of olfactory auras.
Open AccessOlfactory Auras in Patients with Temporal Lobe Epilepsy
Summary: Purpose: To investigate olfactory auras in patients with temporal lobe epilepsy (TLE).Methods: We reviewed medical records of 217 Chinese patients who underwent temporal lobectomy for medically intractable TLE between 1987 and 1998 in Taiwan. Patients with olfactory auras asked for detailed characteristics of their auras.Results: In all, 12 (5.5%) patients had olfactory auras, seven men and five women. All patients except one described and characterized the unpleasant olfactory auras. Olfactory auras were usually combined with other auras, most frequently sensations of epigastric rising, nausea, and fear. Association with gustatory hallucination was uncommon, in only one patient. On neuroimaging study, 11 patients had structural lesions involving the mesial temporal structures, two exclusively involving the amygdala. Histologic diagnosis included gliosis of the mesial temporal regions in seven (58.3%) patients, neoplasm in four (33.3%) patients, and arteriovenous malformation in one patient. Postoperatively, eight patients were seizure free. Three patients had rare seizures; however, none reported residual olfactory auras.Conclusions: Olfactory auras are infrequent in TLE. In this study, mesial temporal sclerosis is the most common etiology rather than tumors. Mesial temporal structures, especially the amygdala, may play important roles in the genesis of olfactory auras.
- Open Access
Antiepileptic Drug Withdrawal in Patients with Temporal Lobe Epilepsy Undergoing Presurgical Video‐EEG Monitoring
Summary: Purpose: To investigate antiepileptic drug (AED) withdrawal during video‐EEG monitoring in adult patients with temporal lobe epilepsy (TLE). Methods: Between 1995 and 1997, 102 consecutive patients with refractory TLE were admitted to the epilepsy monitoring unit for presurgical evaluation. Patients were monitored with ongoing AEDs being rapidly decreased and discontinued in 4–6 days. The monitoring was continued until sufficient numbers of seizures were recorded. Serum AED levels were checked at admission and after the first complex partial seizure (CPS). Results: In all, 89 patients had 429 CPSs (mean, 4.8 per patient), including 156 (36.4%) secondarily generalized. A mean of 153.8 h (16–451 h) was required for completing the monitoring in each patient. Forty‐three (48.3%) patients experienced seizure clusters, and eight (9.0%) had generalized seizures that had never occurred or had been absent for years. However, none evolved to status epilepticus. Carbamazepine was the most commonly used AED in 71.9% of patients, followed by valproate and phenytoin. When the first CPS occurred, mean 77.2 h since the beginning of the monitoring, serum levels of these three AEDs were mostly subtherapeutic rather than minimal. Conclusions: Acute AED withdrawal effectively provoked seizures in TLE patients undergoing presurgical video‐EEG monitoring. However, nearly 50% of patients had seizure clusters or secondarily generalized seizures. Serum AED levels were mostly subtherapeutic when the first CPS occurred.
Open AccessAntiepileptic Drug Withdrawal in Patients with Temporal Lobe Epilepsy Undergoing Presurgical Video‐EEG Monitoring
Summary: Purpose: To investigate antiepileptic drug (AED) withdrawal during video‐EEG monitoring in adult patients with temporal lobe epilepsy (TLE). Methods: Between 1995 and 1997, 102 consecutive patients with refractory TLE were admitted to the epilepsy monitoring unit for presurgical evaluation. Patients were monitored with ongoing AEDs being rapidly decreased and discontinued in 4–6 days. The monitoring was continued until sufficient numbers of seizures were recorded. Serum AED levels were checked at admission and after the first complex partial seizure (CPS). Results: In all, 89 patients had 429 CPSs (mean, 4.8 per patient), including 156 (36.4%) secondarily generalized. A mean of 153.8 h (16–451 h) was required for completing the monitoring in each patient. Forty‐three (48.3%) patients experienced seizure clusters, and eight (9.0%) had generalized seizures that had never occurred or had been absent for years. However, none evolved to status epilepticus. Carbamazepine was the most commonly used AED in 71.9% of patients, followed by valproate and phenytoin. When the first CPS occurred, mean 77.2 h since the beginning of the monitoring, serum levels of these three AEDs were mostly subtherapeutic rather than minimal. Conclusions: Acute AED withdrawal effectively provoked seizures in TLE patients undergoing presurgical video‐EEG monitoring. However, nearly 50% of patients had seizure clusters or secondarily generalized seizures. Serum AED levels were mostly subtherapeutic when the first CPS occurred.
- Open Access
A Double‐Blind, Placebo‐Controlled Study of Topiramate in Adult Patients with Refractory Partial Epilepsy
Summary: Purpose: The efficacy and safety of topiramate (TPM) as adjunctive therapy in the treatment of adult Chinese patients with refractory partial epilepsy were investigated in a randomized, double‐blind, placebo‐controlled study. Methods: A total of 46 patients who had four or more complex partial seizures with or without secondary generalization within an 8‐week baseline phase were enrolled. Patients were assigned randomly to receive TPM (n = 23) or placcbo (n = 23). TPM or placebo was titrated to target doses of 300 mg/d for 6 weeks and maintained at stabilized levels for another 8 weeks. Concomitant antiepileptic drugs remained at constant previous levels during the trial. Results: In all, 41 patients completed the trial (TPM group, n = 20; placebo group, n = 21). The proportion of patients with a 50% reduction from baseline in complex partial seizures was 11 of 23 (47.8%) in the TPM group and 3 of 23 (13.0%) in the placebo group (p = 0.01). In addition, patients treated with TPM had significantly better investigator (p = 0.014) and patient (p = 0.0005) global assessment scores than patients in the placebo group. Adverse events were mostly mild and transient, with no significant differences between treatment groups. Two patients with TPM therapy complained of weight loss. Routine blood cell counts and other laboratory results showed no significant changes from baseline in either treatment group. Conclusions: TPM 300 mg/d is effective and well tolerated as treatment for refractory partial epilepsy in adults.
Open AccessA Double‐Blind, Placebo‐Controlled Study of Topiramate in Adult Patients with Refractory Partial Epilepsy
Summary: Purpose: The efficacy and safety of topiramate (TPM) as adjunctive therapy in the treatment of adult Chinese patients with refractory partial epilepsy were investigated in a randomized, double‐blind, placebo‐controlled study. Methods: A total of 46 patients who had four or more complex partial seizures with or without secondary generalization within an 8‐week baseline phase were enrolled. Patients were assigned randomly to receive TPM (n = 23) or placcbo (n = 23). TPM or placebo was titrated to target doses of 300 mg/d for 6 weeks and maintained at stabilized levels for another 8 weeks. Concomitant antiepileptic drugs remained at constant previous levels during the trial. Results: In all, 41 patients completed the trial (TPM group, n = 20; placebo group, n = 21). The proportion of patients with a 50% reduction from baseline in complex partial seizures was 11 of 23 (47.8%) in the TPM group and 3 of 23 (13.0%) in the placebo group (p = 0.01). In addition, patients treated with TPM had significantly better investigator (p = 0.014) and patient (p = 0.0005) global assessment scores than patients in the placebo group. Adverse events were mostly mild and transient, with no significant differences between treatment groups. Two patients with TPM therapy complained of weight loss. Routine blood cell counts and other laboratory results showed no significant changes from baseline in either treatment group. Conclusions: TPM 300 mg/d is effective and well tolerated as treatment for refractory partial epilepsy in adults.